NCT02425202View on ClinicalTrials.gov

Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

May 3, 2018

Study Completion Date

May 3, 2018

Conditions
Obstructive Sleep Apnea Syndrome
Interventions
DRUG

Ketamine

Post-operative continuous infusion until 0600 the next day

OTHER

Saline infusion

Post-operative continuous infusion until 0600 the next day

Trial Locations (1)

R3A 1S1

Health Sciences Center, Winnipeg

All Listed Sponsors
lead

University of Manitoba

OTHER

NCT02425202 - Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy | Biotech Hunter | Biotech Hunter